Last reviewed · How we verify
DHP1401
At a glance
| Generic name | DHP1401 |
|---|---|
| Also known as | DHP1401 500mg or 1,000mg |
| Sponsor | Daehwa Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DHP1401 CI brief — competitive landscape report
- DHP1401 updates RSS · CI watch RSS
- Daehwa Pharmaceutical Co., Ltd. portfolio CI